Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine "
Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation ."
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary . Washington, DC: The National Academies Press,
Please select a format: